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Fig. 1  
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MG-63  RPMI 1640 D-(+)-Glucose 
L-Glutamine Phenol Red 10% FBS 0.5% 
Penicillin-Streptomycin  37℃ 5% CO2
mRNA
qRT-Real time PCR  
Western blot  WST-1
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Fig. 2  
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H2452 RPMI 1640 D-(+)-Glucose 
L-Glutamine Phenol Red 10% FBS 0.5% 
Penicillin-Streptomycin 1% HEPES 1% 
Glucose 1% Sodium pyruvate  37℃ 
5% CO2
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